/PRNewswire/ With many U.S. cities considering a ban on natural gas hookups in new-construction homes due to recent health-study findings, the range hood is.
MIVI Neuroscience Secures Series B Funding
News provided by
Share this article
Share this article
EDEN PRAIRIE, Minn., Jan. 21, 2021 /PRNewswire/ MIVI Neuroscience, a medical device company focused on improving clinical outcomes for ischemic stroke patients, today announced the closing of its Series B funding including $35 million in new money plus the conversion of previously issued convertible notes. The funding was led by a major multinational med-tech company and included participation from new investors Perceptive Advisors, Deerfield Management and Aphelion / Cardeation Capital as well as existing investors including Concord Health Partners. Raymond James & Associates, Inc. acted as sole placement agent for the transaction.